TruthArchive.ai - Related Video Feed

We are facing a new disease involving white clots found in post-mortem bodies, made of fibrin, platelets, and amyloid protein. Embalmers reported 20% of corpses showing these clots in 2023, a significant increase from previous years. These clots are not seen in pathology textbooks and need urgent investigation. Therapeutic interventions should be suspended until the cause is determined. This new pathology is present in about 20% of corpses, indicating a concerning trend. More details will be provided in the next video.

The speaker presents an illustration of clots removed from a 30-year-old man, noting the largest clot came from the femoral artery while two of the smaller clots came from the radial arteries. The footage is described as zoomed in so viewers can see that these clots are not natural and have come from inside the arteries. The speaker emphasizes that these clots are not a normal finding inside a young man of 30 years old, repeatedly asserting that “these are not natural” and “these shouldn’t be inside this young man of 30 years old.” The presenter then remarks that the case is “imprisoned and deceased in The UK,” linking the observation to events or revelations associated with Richard Hirschman. The speaker indicates an attempt to examine the clots more closely, explaining the lack of equipment (no microscope) but insisting on the visible reality of clots sitting inside the arteries, and rhetorically questions whether this is normal. The final claim made is that the individual from whom the clots were removed was a jab recipient, tying the medical observation to vaccination. Throughout, the speaker frames the findings as alarming and abnormal, stressing the combination of young age, arterial clots, and a vaccination context, while invoking Hirschman’s revelations and noting the location as The United Kingdom.

Dr. Pretorius and a colleague discuss unusual clotting observed after COVID-19 vaccination, including embalmers reporting back pressure when introducing embalming fluid and the extraction of very long, congealed clots—six inches to several feet—as well as patients with long brachial clots. They note thousands of clotting reports in VAERS across all vaccine types, describing these clots as not normal. Some clots cause major emboli affecting circulation to the lungs, detected by scans and perfusion studies, while others are microclots with a branching pattern visible in imaging. A clinician also shared a photo of a clot with a complete branching pattern into medium and smaller vessels. Dr. Pretorius’ work is cited to explain the mechanism: spike protein can induce immediate clumping of proteins in platelet-poor plasma in the absence of platelets, a highly unusual clotting pathway not relying on the classical coagulation cascade. This is described as a proteinaceous, pseudo-amyloid–like clot. The spike protein is reported to circulate after vaccination, with studies in the Journal of Immunology showing spikes in circulation and exosomes up to four months after shots. Long-haul COVID data (Patterson’s study) reportedly shows S1 protein present in nonclassical monocytes in blood, suggesting persistence of spike protein, whether from infection or the vaccine, which can induce clotting pathways on its own. Dr. Pretorius discusses observations of upregulation of intercellular adhesion molecules (ICAMs) on leukocytes within clots, causing white blood cells to adhere in addition to fibrin, contributing to difficulty in dissolving these clots. Concerning treatment and detection, the speakers describe depletion of plasminogen, reducing the body’s ability to break down clots, and note that standard anticoagulants are less effective against these clots, which are described as amyloid-like and atypical. They emphasize that these are not the classical clotting pathways involving platelet activation and typical thrombin–fibrin cascades. They contrast this with expectations of standard clotting mechanisms and reference the unusual, non-classical pathway highlighted by Pretorius. The discussion also mentions the idea that spike protein in circulation can drive clotting without the usual platelet activation, and that some patients have continued to experience spike-related effects long after vaccination. They assert that vaccines were developed targeting the original Wuhan strain and may not cover Omicron; they suggest the shot’s risk-benefit balance is unfavorable given ongoing clotting, immune suppression, and cancer-inducing pathways, and they claim data indicate those who receive two or three shots may acquire Omicron at a higher rate than those unvaccinated. They conclude that the shot is expired for a virus that is no longer circulating in its original form and argue that vaccination induces dangerous pathologic processes with no protective benefit.

Speaker: A lot of the analysis techniques that were being employed now on the white clots. And about three years ago, there was one piece of analyses that I came across just by accident, which was a thing called an ICP analysis, which is an analysis that determines the elements present in white clots. It was done by a gentleman in The USA called Mike Adams, who presented the findings of his initial white clot analysis from samples that Richard had provided him some almost three years ago now. And it surprised me what the findings were, because I have used the ICP analysis. It’s called Inductively Coupled Plasma Mass Spectrometry. Don't worry about the name. It's just a very well known piece of analytical equipment that you can rely upon to tell you what elements are there in the white clot and in what abundance. And what surprised me was in the analysis that Mike presented was a very the highest element they found was phosphorus, followed by sodium, tin, and later on sulphur, and carbon. And we also found that there were no normal blood marker elements present in the white clots. So, we've actually employed two laboratories in Europe, and there's a long reason behind that because I'm associated with people in Europe who do this kind of work. Anyway, we sent clot samples, they all ran ICP analyses. They found exactly the same results that Mike Adams found. We found aberrantly high levels of phosphorus, we found aberrantly high levels of sulphur, tin, sodium, and carbon. And being an organic chemist, I know a little bit about tin chemistry, because I used to sell tin catalysts, believe it or not, for polymerisation reactions. So I had to study the chemistry of tin. And I wondered why tin would be present in a white clot. So, obviously, we could not believe this first series of results. It's set about replicating the results in two separate labs, and they came back and said, you're right, there's high levels of phosphorus, tin, sulfon, carbon. So the next thing we did was to do an analysis called HPLC, High Performance Liquid Chromatography. And what this does is actually pulls apart the white clots and tells you what the protein components are. And surprisingly, we found that the highest level of proteins we found was fibrinogen. But the HPLC analysis actually will determine what kinds of fibrinogen chains are there. In a normal red blood clot, there's normally one to one to one ratio of the alpha chain, beta chain and gamma chain. We found in our white clots that the beta chain far exceeded the alpha chain and the gamma chain. And in fact, it was beta gamma alpha. So the alpha was the lowest proportion. Now, we're not biochemists, and we're not medically qualified in any way. But we can do simple research to find out why the fibrinogen content was so high. Fibrinogen forms fibrils. This is exactly why when John O'Learny first described the white clots as being calamari like, he is exactly correct. That's exactly the texture that fibrin will bring into a white clot. Okay, so from then on, we then ran some amino analysis results. My colleagues ran an amino acid analysis, and they found a high level of Praline, Aspartic acid, Lysine, a whole range of about 18 amino acids, all that have a phosphorus affinity. And as we said in the white clot, the element that has the highest concentration that we could confirm is porpoise. If you take time then to research the aberrant pathways that what they call excess phosphorylation will cause, it causes a whole range of problems in the human body. So we have determined, we think, the pathway to the formation of these white clots. We have three separate pieces of analysis, all confirming our findings. So we've now pieced together the formation of the white clots, and I'll come back to the very beginning. When we administer the injections, there is a lipid nanoparticle carrier, it's called a phospholipid. We found by our analysis that when the phospholipid releases the mRNA core of the lipid nanoparticle, at the very moment that it releases the core, it actually exposes a phosphorus head of the phosphorus lipid. The phosphor lipid reacts within the bloodstream naturally formed fibrinogen, and that's what's nucleating the white clot formation. Now we can prove all this. We've actually got over 200 peer reviewed papers confirming the pathway that I'm describing. And more importantly, once that initiation of the DSPC now the actual phospholipid that is encapsulating the lipid nanoparticle is a phospholipid called DSPC. I won't go into the name of it, but what it means is that that particular phospholipid we found, again through research, that it will liberate 80 to 90% of raw phosphorus heads as it releases the mRNA core. Those phosphorus heads all react with the fibrinogen in the bloodstream and they cause sandy blood. The reason you guys are seeing sandy blood and coffee grounds is that's the nucleation pathway to the final white clot formation. The other factor we found and proved the spike protein bonds to the phosphorylated fibrinogen. The body is generating methylcetiopridine generated spike, that spike in the bloodstream then starts to coagulate with the phosphorylated fibrinogen, and that feeds what we call a monomeric reaction that continues to grow. Those particles are free flowing in the blood and they find an anchor point. The anchor points they find are in fact the damaged endothelial layers. When an endothelial layer of the vascular system is damaged via inflammation and the cytokine storm that the spike protein generates, That opens up the natural phospholipid layer of the endothelial layer, and that forms anchor points for these nuclei. From these anchor points, that's when the clots begin to grow. So, I'm trying to encapsulate this in a very simple term. It's quite a complex number. Very

In this video, the speaker discusses the presence of white fibrous clots in bodies. They conducted a survey last year to determine if this phenomenon was real. The survey revealed that around 70% of embalmers were seeing these clots, with most of them noticing them after the rollout of vaccines in 2021. Some embalmers reported seeing these clots in up to 50% or more of the corpses they worked with. The speaker is currently conducting another survey to gather more information on what embalmers are observing in 2023.

Tom Haviland, a retired major in the US Air Force and an experienced embalmer, discusses the presence of white fibrous clots found in the circulatory systems of deceased individuals. These clots, which have been observed in a high percentage of corpses over the past three years, are believed to be made of amyloid protein and fibrin. Embalmers have noticed an increase in the size and prevalence of these clots, as well as an increase in microclotting or "coffee ground" clots. The data collected from embalmers suggests that these clots may be linked to the spike protein produced by the COVID-19 vaccines.

The clots being formed, we've run mass spectrometry on these clots. They don't look like normal clots. They don't have the same composition. They don't have fibrin. They don't have thrombin, which are normal things you would see in a normal coagulation cascade. They have, instead, all the fibrinogen chains—alpha, beta, and gamma. They have them in a strange differential where it's not one-to-one-to-one; it's about 36 to 16 to 4 by ratios. They're aberrantly cross-linked by sulfide bonds. There's a ton of tin for some reason. I don't know why there's tin in there, but there's a ton of tin in there and a ton of phosphorus. And the spike protein is actually coated in GLIKNAK, which is a phosphate donor. So that might explain all the phosphorus if it's providing the energetics or in some way by cleaving or creating phosphate bonds. So I think that that's a big problem because that's a slow progression of coagulopathy that's, I think, narrowing the lumens of the vascular system, which is contributing to some of the organ failure that we're seeing, some of the neurological symptomatology that we're seeing, some of the fatigue, and things of that nature. And then finally, the spike protein is shown to produce—it’s shown to induce misfolding of proteins and actually

I've examined blood samples and have observed anomalies in everyone I've tested, even myself. I'm now seeing things I never saw in un*vaxxed individuals before. I'm noticing unusual formations, like chains potentially building, which typically occurs when the blood is breaking down. These formations seem more noticeable during decomposition. What's interesting is that while the body decomposes, these anomalies don't. They change and morph into something else. The red blood cells are visible, but when these formations mass together, that's when they evolve or morph. It could happen at any moment.

I washed my slides and found anomalies in everyone's blood, including my own. These anomalies resemble liver congestion and may form chains as blood breaks down. They do not decompose like the rest of the body, but instead morph into something else, possibly evolving further. The process of transformation is ongoing and could happen at any moment.

I washed my slides and found similar anomalies in everyone, including myself, which I hadn't seen in the unvaccinated before. I observe my blood regularly, and I've noticed some unusual formations that resemble liver congestion. These changes seem to become more apparent as the body decomposes, yet the anomalies themselves do not decompose; they morph into different forms. The red blood cells are present, but when they gather into masses, they begin to evolve. This process hasn't started yet, but it could happen at any moment.

I'm at the funeral home with some guys. There's a clot in the iliac artery, which is unusual. The clots got worse over time. We tried draining fluid from the carotid artery but it stopped. A big clot came out, surprising us. The only way to see this in the body is through internal examination.

In the past, we did not see blood clotting like this before COVID-19 vaccinations. A marathon runner had severe issues walking after vaccination, requiring treatments like plasma freezes. Clot formations indicate ongoing damage to blood vessel linings, leading to clot formation. Multiple vaccinated individuals experience circulation problems in cold temperatures, with symptoms improving in warmer weather.

A UK doctor and a US cardiologist have whistleblowers revealing an increase in white fibrous clots being removed from patients. Traditional clot-busting drugs are ineffective against these clots, requiring manual extraction in cath labs. The whistleblowers link the presence of these clots to COVID vaccine recipients, with 99% of patients having received 1 to 8 doses. The issue worsens with more vaccine doses. The whistleblowers fear repercussions for speaking out.

In this video, Richard Hirschman, an embalmer, discusses the abnormal blood clotting issues he has observed in bodies since early 2021. He shares that these clots are different from typical blood clots, as they are white, fibrous, and rubbery in texture. Hirschman believes that these clots may be caused by aberrant proteins resulting from the COVID vaccines. He emphasizes the need for further research and understanding of these clots and their potential impact on health. Another guest, Jamie, a funeral service professional, supports Hirschman's observations and urges people to critically evaluate the situation. The video also includes a discussion on the suppression of information and the need for scientific investigation.

A data analyst and former Air Force Major conducted a survey among embalmers nationwide. 72% reported seeing white fibrous blood clots in corpses in 2023. The analyst, Tom Haviland, conducted the survey after hearing reports of these clots. He sent out surveys to over 3 dozen funeral associations and 1700 funeral homes worldwide. The survey found that 7 out of 10 embalmers observed the clots, with most seeing them after the vaccine rollout in 2021. A follow-up survey is currently underway to gather more data for 2023.

There are real cases of blood clots in patients who have received the vaccine. These clots are thick and fibrous and can be seen in living patients. A tube of blood from a patient with cold-induced finger pain showed the same fibrils as the clots. The body has difficulty breaking down the material in the clots, including amyloid. Autopsies were discouraged early on, so these clots may not have been discovered. Morticians have noticed unusual back pressure when preserving bodies. The clots contain collected proteins and unusual combinations that are hard to dissolve. Nattokinase, an enzyme found in fermented soy, can break down fibrin and may be helpful in dissolving clots.

Last year, a survey was conducted to investigate the phenomenon of white fibrous clots seen by embalmers. The survey reached out to various funeral director associations and funeral homes worldwide. The results showed that around 70% of embalmers were observing these clots, with most of them noticing them after the vaccine rollout in 2021. Some embalmers reported seeing the clots in over 50% of the bodies they worked on. Another survey is currently underway to gather data on embalmers' observations in 2023.

I recently conducted a survey of embalmers, and 73% of the 269 respondents reported finding white fibrous clots in corpses during 2023. These clots, which consist of fibrin, platelets, and amyloid-like material, are suspected to be a contributing factor in strokes and heart attacks. Embalmers are finding these clots are making it necessary to use multiple injection sites, lengthening the embalming process. While similar clots were observed in 2020, during the initial COVID outbreak, their prevalence exploded with the introduction of vaccines in 2021. The spike protein from the virus and vaccines may be responsible for the formation of these clots. Additionally, embalmers are reporting increases in microclotting and traditional grape jelly clots. One theory suggests "frame shifting," where ribosomes misread the modified RNA code from vaccines, creating aberrant proteins that form amyloid material. I can be contacted at thomashaveland@sbcglobal.net.

The speaker discusses changes observed in the blood, including increased viscosity and the presence of small clots and color changes. They mention a strange phenomenon that occurred in the spring of 2021, where they initially thought they saw a parasite in the circulatory system. This anomaly was unlike anything they had seen in their 25-year career as an embalmer. Over time, these occurrences became more common and the clots grew larger, with integrated jelly clots appearing at the end. The speaker describes these integrated jelly clots as resembling erasers with tentacles and blood clots attached, leading them to wonder if they were parasites feeding off the human circulatory system.

These fibrous, strong, rubber band-like structures came from a deceased person's body. These are not blood clots, but "engineered biostructures" being built inside people's arteries. Skeptics might mistake them for blood vessels, but high-resolution images reveal repeating patterns resembling reptilian scales. These structures don't belong in the human body and are found in people who "died suddenly." Embalmers report never seeing them before a certain time. While such occurrences were once rare, they have skyrocketed, appearing in relatively young patients in their 40s, 50s, and 60s. Previously, these issues were primarily seen in older patients with known heart disease.

White fibrous clots found in the living and dead recipients of mRNA vaccines are being ignored, but research reveals their composition and cause. The spike protein mutates fibrin into jagged, misfolded, insoluble amyloid, similar to prionic infections. Microclots form and align into large white clots, initiated by spike protein fragments like spike 601. Prolene, a "kinker protein" added to the spike protein, causes misfolding, with proline being prevalent in the clots. A 2021 paper showed the SARS CoV-2 spike induces abnormal blood clots due to the fibrinogen beta chain. Plasma exposed to the spike protein is imbalanced, with the fibrinogen beta chain being dominant. These clots contain four times the normal amount of phosphorus, released from lipid nanoparticles. Similar clots in 1988 were caused by sulfur-based heparin, which was resolved by reducing sulfur content. A 2017 paper showed altered phosphorus levels cause cancer. Thomas Havilland, who shares this information, is being ignored by mainstream and alternative media. Undertakers are seeing massive white fibrous clots at record levels.

I washed my slides and examined blood samples from everyone, including myself. I noticed some anomalies that I hadn't seen in unvaccinated individuals before. These anomalies appear when the blood starts breaking down, particularly during decomposition. Interestingly, while the blood changes, the anomalies do not decompose; instead, they morph into different forms. The red blood cells are present, but when they cluster together, they begin to evolve into something else. This transformation could happen at any moment.

Speaker 0 describes an ICP analysis (Inductively Coupled Plasma Mass Spectrometry) of white clots, initially encountered about three years ago from samples provided by Richard. Mike Adams presented the initial findings. The ICP analysis showed the highest element in the white clots was phosphorus, followed by sodium, tin, then sulfur and carbon. They also found that there were no normal blood marker elements present in the white clots. Two laboratories in Europe were used to replicate the results; both reported aberrantly high levels of phosphorus, tin, sulfur, sodium, and carbon. To investigate further, they performed High Performance Liquid Chromatography (HPLC) to identify protein components. The highest level of protein found was fibrinogen. The HPLC analysis determined the kinds of fibrinogen chains present, and it showed that in the white clots the beta chain far exceeded the alpha and gamma chains, with a beta-gamma-alpha ratio. They noted they were not biochemists or medically qualified, but conducted simple research to understand why fibrinogen content was so high. Fibrinogen forms fibrils, which aligns with John O’Learny’s description of white clots as calamari-like in texture, matching the expected texture from fibrin. An amino acid analysis by colleagues revealed high levels of proline, aspartic acid, lysine, and about 18 other amino acids, all with phosphorus affinity. They reiterate that the element with the highest confirmed concentration in the white clot is phosphorus. They state that aberrant phosphorylation pathways can cause a range of problems in the human body. They claim three separate pieces of analysis confirm their findings, allowing them to piece together the pathway to the formation of white clots. They connect this to injections that use a lipid nanoparticle carrier, specifically a phospholipid. Their analysis indicates that when the phospholipid releases the mRNA core of the lipid nanoparticle, it exposes a phosphorus head of the phospholipid. The phospholipid reacts within the bloodstream with naturally formed fibrinogen, nucleating the white clot formation. They claim over 200 peer-reviewed papers confirm the pathway described. They specify that the DSPC phospholipid encapsulating the lipid nanoparticle liberates 80 to 90% of raw phosphorus heads as it releases the mRNA core. Those phosphorus heads react with fibrinogen in the bloodstream, causing the sandy blood and coffee-ground appearance as the nucleation pathway to final white clot formation. They add that the spike protein binds to phosphorylated fibrinogen; the body generates methylcetiopridine-generated spike protein in the bloodstream, which coagulates with phosphorylated fibrinogen, feeding a monomeric reaction that continues to grow. These particles are free-flowing in the blood and find anchor points on damaged endothelial layers. When endothelial layers are damaged via inflammation and the cytokine storm induced by the spike protein, the natural phospholipid layer of the endothelium opens up and forms anchor points for these nuclei. From these anchor points, the clots begin to grow. They acknowledge the complexity but describe this as a simple encapsulation of the process.

In this video, the speaker discusses a documentary about embalmers finding strange white fibrous clots in corpses. They highlight a statement made by an embalmer at a conference, where all attendees claimed to have seen these clots after the rollout of safe injections. The speaker contacts the Ohio Embalmers Association and confirms that the vice president also sees these clots. This prompts the speaker to conduct a survey, which reveals that 66% of embalmers have witnessed the clots, with some seeing them in up to 50% of corpses. The clots can be as long as 2 feet and may cause strokes and heart attacks by blocking veins and arteries.

People have these massive biostructures growing inside their arteries and blood vessels, which are not blood clots but engineered biostructures. These structures are made of repeating patterns that resemble reptilian scales. It is shocking because these structures should not be in the human body. Embalmers have never seen them until recently. The occurrence of these structures has skyrocketed, even in relatively young patients. Typically, heart disease is seen in older individuals, but now it is being observed in people in their forties, fifties, and sixties. Usually, patients with heart disease also have blockages in other parts of their body.